These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26517534)

  • 1. New Genetic Forms of Childhood-Onset Primary Osteoporosis.
    Kämpe AJ; Mäkitie RE; Mäkitie O
    Horm Res Paediatr; 2015; 84(6):361-9. PubMed ID: 26517534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.
    Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O
    J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
    Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
    J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Discoveries in Monogenic Disorders of Childhood Bone Fragility.
    Mäkitie RE; Kämpe AJ; Taylan F; Mäkitie O
    Curr Osteoporos Rep; 2017 Aug; 15(4):303-310. PubMed ID: 28646443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.
    Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O
    J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLS3 mutations in X-linked osteoporosis with fractures.
    van Dijk FS; Zillikens MC; Micha D; Riessland M; Marcelis CL; de Die-Smulders CE; Milbradt J; Franken AA; Harsevoort AJ; Lichtenbelt KD; Pruijs HE; Rubio-Gozalbo ME; Zwertbroek R; Moutaouakil Y; Egthuijsen J; Hammerschmidt M; Bijman R; Semeins CM; Bakker AD; Everts V; Klein-Nulend J; Campos-Obando N; Hofman A; te Meerman GJ; Verkerk AJ; Uitterlinden AG; Maugeri A; Sistermans EA; Waisfisz Q; Meijers-Heijboer H; Wirth B; Simon ME; Pals G
    N Engl J Med; 2013 Oct; 369(16):1529-36. PubMed ID: 24088043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Lv F; Ma M; Liu W; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X; Qiu Z; Li M
    Osteoporos Int; 2017 Sep; 28(9):2691-2700. PubMed ID: 28620780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.
    Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J
    Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.
    Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F
    J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis.
    Wu Z; Feng Z; Zhu X; Dai Z; Min K; Qiu Y; Yi L; Xu L; Zhu Z
    Orphanet J Rare Dis; 2022 Jun; 17(1):247. PubMed ID: 35752817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations.
    Palomo T; Al-Jallad H; Moffatt P; Glorieux FH; Lentle B; Roschger P; Klaushofer K; Rauch F
    Bone; 2014 Oct; 67():63-70. PubMed ID: 25010833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O
    Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
    Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
    J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults.
    Mäkitie RE; Haanpää M; Valta H; Pekkinen M; Laine CM; Lehesjoki AE; Schalin-Jäntti C; Mäkitie O
    J Bone Miner Res; 2016 Sep; 31(9):1734-42. PubMed ID: 27005318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in WNT1 cause different forms of bone fragility.
    Keupp K; Beleggia F; Kayserili H; Barnes AM; Steiner M; Semler O; Fischer B; Yigit G; Janda CY; Becker J; Breer S; Altunoglu U; Grünhagen J; Krawitz P; Hecht J; Schinke T; Makareeva E; Lausch E; Cankaya T; Caparrós-Martín JA; Lapunzina P; Temtamy S; Aglan M; Zabel B; Eysel P; Koerber F; Leikin S; Garcia KC; Netzer C; Schönau E; Ruiz-Perez VL; Mundlos S; Amling M; Kornak U; Marini J; Wollnik B
    Am J Hum Genet; 2013 Apr; 92(4):565-74. PubMed ID: 23499309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plastin 3 influences bone homeostasis through regulation of osteoclast activity.
    Neugebauer J; Heilig J; Hosseinibarkooie S; Ross BC; Mendoza-Ferreira N; Nolte F; Peters M; Hölker I; Hupperich K; Tschanz T; Grysko V; Zaucke F; Niehoff A; Wirth B
    Hum Mol Genet; 2018 Dec; 27(24):4249-4262. PubMed ID: 30204862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in
    Brlek P; Antičević D; Molnar V; Matišić V; Robinson K; Aradhya S; Krpan D; Primorac D
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel frameshift deletion in PLS3 causing severe primary osteoporosis.
    Costantini A; Krallis PΝ; Kämpe A; Karavitakis EM; Taylan F; Mäkitie O; Doulgeraki A
    J Hum Genet; 2018 Aug; 63(8):923-926. PubMed ID: 29884797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.